Mapping the characteristics, methodological quality and standards of reporting of network meta-analyses on antithrombotic therapies: An overview

•A mapping and critically appraised the standards of conduction and reporting of NMA assessing antithrombotic therapies.•Around 75% of NMA stated following guidelines for conduction and reporting, only one-third provided a protocol/Register.•According to AMSTAR-2, most of the evaluated studies have critically low methodological quality and low adherence to PRISMA-NMA.•Try to Understand why the guidelines for conducting and reporting aren't being strictly followed would be an interesting path.